Below is an overview of the most significant follow-up projects that continue the scientific and research focus of the CarDia National Institute project and further build upon the results achieved during its implementation.
These projects make it possible to maintain the continuity of research activities, expand upon the knowledge gained, and apply it to other areas of development, clinical practice, and interdisciplinary collaboration. At the same time, they provide an important financial framework for continuing scientific work, as funds designated for financing the research itself are no longer available during the project’s sustainability period.
Follow-up projects thus ensure not only the further professional development of topics initiated in the National CarDia Institute project, but also stable conditions for the continuation of the team’s research and innovation activities.
Obesity is defined as weight gain above the normal limit due to excessive accumulation of adipose tissue in the body. Obesity is determined by the body mass index (BMI), which is calculated as the ratio of body weight in kilograms to the square of body height in metres. The increasing prevalence of obesity is a major health problem in virtually all developed countries of the world. In the Czech Republic, more than half of the adult population is overweight (defined as a BMI between 25-29.9 kg/m2 ) or obese (BMI > 30 kg/m2 ), and the number is increasing.
Diabetes mellitus is a disease caused by a long-term increase in blood glucose (sugar) levels. If diabetes is not adequately treated, elevated glycaemia levels lead to serious complications, especially increased risk of cardiovascular disease (heart attack, stroke), reduced life expectancy, and damage to eyesight, nerves and kidneys.
Although cardiovascular disease mortality rates are steadily declining, they are still the most common cause of death in most European countries, including the Czech Republic, where they are responsible for half of all deaths. Yet the Czech Republic lags far behind Western Europe. Compared to France, the death rate from these diseases is almost three times higher.